CF
CNA Financial Portfolio holdings
AUM
$195M
This Quarter Return
-6.57%
1 Year Return
+20.43%
3 Year Return
+79.36%
5 Year Return
+144.91%
10 Year Return
+226.32%
AUM
$322M
AUM Growth
+$322M
(-16%)
Cap. Flow
-$24.3M
Cap. Flow
% of AUM
-7.55%
Top 10 Holdings %
Top 10 Hldgs %
31.34%
Holding
203
New
11
Increased
51
Reduced
71
Closed
16
Top Buys
| 1 |
Cheniere Energy
LNG
|
$6.93M |
| 2 |
Morgan Stanley
MS
|
$6.12M |
| 3 |
Hanesbrands
HBI
|
$4.47M |
| 4 |
Meta Platforms (Facebook)
META
|
$4M |
| 5 |
General Motors
GM
|
$3.94M |
Top Sells
| 1 |
Pfizer
PFE
|
$8.86M |
| 2 |
CoStar Group
CSGP
|
$7.11M |
| 3 |
CME Group
CME
|
$6.17M |
| 4 |
Jacobs Solutions
J
|
$5.57M |
| 5 |
JPMorgan Chase
JPM
|
$4.75M |
Sector Composition
| 1 | Technology | 22.54% |
| 2 | Healthcare | 19.56% |
| 3 | Consumer Discretionary | 14.54% |
| 4 | Industrials | 8.94% |
| 5 | Financials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Madison Square Garden
MSGS
$4.69B
| $472K | 0.15% |
2,631
| – | – |
|
|
FSR
152
DELISTED
Fisker Inc.
FSR
| $467K | 0.14% |
36,190
+3,610
| +11% | +$46.6K |
|
153
ACV Auctions
ACVA
$1.99B
| $465K | 0.14% |
+31,412
| New | +$465K |
|
154
Relay Therapeutics
RLAY
$633M
| $465K | 0.14% |
15,549
-440
| -3% | -$13.2K |
|
155
PAR Technology
PAR
$2.01B
| $437K | 0.14% |
+10,840
| New | +$437K |
|
156
Liberty Broadband Class C
LBRDK
$8.66B
| $435K | 0.13% |
3,217
| – | – |
|
157
Freshpet
FRPT
$2.62B
| $412K | 0.13% |
4,010
-800
| -17% | -$82.2K |
|
|
ALTR
158
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $406K | 0.13% |
6,311
| – | – |
|
159
Ultragenyx Pharmaceutical
RARE
$3.08B
| $402K | 0.12% |
5,530
-40
| -0.7% | -$2.91K |
|
160
Vir Biotechnology
VIR
$696M
| $400K | 0.12% |
15,542
+1,790
| +13% | +$46.1K |
|
161
Ascendis Pharma
ASND
$12.2B
| $389K | 0.12% |
3,315
-251
| -7% | -$29.5K |
|
162
Braze
BRZE
$2.85B
| $386K | 0.12% |
9,297
+700
| +8% | +$29.1K |
|
163
Coherus Oncology, Inc. Common Stock
CHRS
$137M
| $377K | 0.12% |
29,191
-110
| -0.4% | -$1.42K |
|
164
Zentalis Pharmaceuticals
ZNTL
$124M
| $377K | 0.12% |
8,176
+220
| +3% | +$10.1K |
|
165
Legend Biotech
LEGN
$6.38B
| $365K | 0.11% |
10,055
-290
| -3% | -$10.5K |
|
166
Grid Dynamics Holdings
GDYN
$674M
| $360K | 0.11% |
25,595
-2,012
| -7% | -$28.3K |
|
|
BHVN
167
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $356K | 0.11% |
3,000
-2,720
| -48% | -$323K |
|
168
WIX.com
WIX
$7.7B
| $343K | 0.11% |
3,285
-496
| -13% | -$51.8K |
|
169
MaxCyte
MXCT
$143M
| $335K | 0.1% |
47,974
-11,929
| -20% | -$83.3K |
|
170
iTeos Therapeutics
ITOS
| $324K | 0.1% |
10,055
-2,520
| -20% | -$81.2K |
|
171
P10
PX
$1.34B
| $322K | 0.1% |
26,608
| – | – |
|
172
DraftKings
DKNG
$23.6B
| $303K | 0.09% |
15,567
-3,653
| -19% | -$71.1K |
|
173
Y-mAbs Therapeutics
YMAB
$389M
| $302K | 0.09% |
25,450
+7,220
| +40% | +$85.7K |
|
|
ENFN
174
DELISTED
Enfusion, Inc.
ENFN
| $289K | 0.09% |
22,759
| – | – |
|
175
Vital Farms
VITL
$2.34B
| $268K | 0.08% |
21,697
| – | – |
|